Title |
Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer
|
---|---|
Published in |
PLOS ONE, July 2013
|
DOI | 10.1371/journal.pone.0068561 |
Pubmed ID | |
Authors |
Paul Toomey, Krithika Kodumudi, Amy Weber, Lisa Kuhn, Ellen Moore, Amod A. Sarnaik, Shari Pilon-Thomas |
Abstract |
Intralesional (IL) injection of PV-10 has shown to induce regression of both injected and non-injected lesions in patients with melanoma. To determine an underlying immune mechanism, the murine B16 melanoma model and the MT-901 breast cancer model were utilized. In BALB/c mice bearing MT-901 breast cancer, injection of PV-10 led to regression of injected and untreated contralateral subcutaneous lesions. In a murine model of melanoma, B16 cells were injected into C57BL/6 mice to establish one subcutaneous tumor and multiple lung lesions. Treatment of the subcutaneous lesion with a single injection of IL PV-10 led to regression of the injected lesion as well as the distant B16 melanoma lung metastases. Anti-tumor immune responses were measured in splenocytes collected from mice treated with IL PBS or PV-10. Splenocytes isolated from tumor bearing mice treated with IL PV-10 demonstrated enhanced tumor-specific IFN-gamma production compared to splenocytes from PBS-treated mice in both models. In addition, a significant increase in lysis of B16 cells by T cells isolated after PV-10 treatment was observed. Transfer of T cells isolated from tumor-bearing mice treated with IL PV-10 led to tumor regression in mice bearing B16 melanoma. These studies establish that IL PV-10 therapy induces tumor-specific T cell-mediated immunity in multiple histologic subtypes and support the concept of combining IL PV10 with immunotherapy for advanced malignancies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 39% |
Spain | 1 | 6% |
Brazil | 1 | 6% |
Grenada | 1 | 6% |
Unknown | 8 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 16 | 89% |
Practitioners (doctors, other healthcare professionals) | 2 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 4% |
Russia | 1 | 2% |
France | 1 | 2% |
Italy | 1 | 2% |
Unknown | 41 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 22% |
Other | 7 | 15% |
Professor > Associate Professor | 6 | 13% |
Researcher | 5 | 11% |
Student > Bachelor | 3 | 7% |
Other | 7 | 15% |
Unknown | 8 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 24% |
Agricultural and Biological Sciences | 9 | 20% |
Biochemistry, Genetics and Molecular Biology | 4 | 9% |
Chemistry | 4 | 9% |
Physics and Astronomy | 2 | 4% |
Other | 7 | 15% |
Unknown | 9 | 20% |